Therapy News and Research

RSS

Understanding long COVID: A call for better diagnosis and treatment

A recent review in Nature Reviews Microbiology summarizes the complex mechanisms, significant impacts, and the urgent need for enhanced diagnostics and treatments for long COVID, affecting over 65 million people globally with diverse, debilitating symptoms and systemic health issues.

7 Mar 2024

Breakthrough in CRISPR delivery promises safer gene editing

Recent research in PNAS highlights advancements in non-viral, cell-specific delivery methods for CRISPR-Cas systems, emphasizing their potential to enhance research and gene therapy applications by minimizing risks associated with off-target effects and improving targeted delivery.

7 Mar 2024

Inherited genetic factors may predict elevated risk of new cancers among childhood cancer survivors

Common inherited genetic factors that predict cancer risk in the general population may also predict elevated risk of new cancers among childhood cancer survivors, according to a study led by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health.

7 Mar 2024

Research on fishing as PTSD treatment gets a $1.3 million funding boost

A "game-changing" $1.3m cash injection has been awarded to researchers exploring if doctors can prescribe fishing to treat PTSD.

7 Mar 2024

Combining virtual reality and electric brain stimulation may be a promising treatment strategy for PTSD

Combining two treatments could be a promising option for people, especially military veterans, whose lives are negatively affected by post-traumatic stress disorder, a new study shows.

7 Mar 2024

When it comes to ketamine, Meta’s posting policy is no party to decipher

People keep talking about ketamine. The drug has become a favorite of celebrities, billionaires, and ordinary patients, many of whom view it as a potential miracle drug for depression and other mental health conditions.

7 Mar 2024

Gut bacteria strains could be the key to predicting cancer treatment success

Researchers discovered that gut microbiota strains can predict the effectiveness and adverse effects of immune checkpoint blockade (ICB) therapy in rare cancer patients.

6 Mar 2024

Research project receives 25 million U.S. dollars to develop drugs against childhood cancers

Cancer is one of the most common causes of death in children worldwide. A research team in which the University of Würzburg is involved wants to change this – and has now received substantial funding for its work.

6 Mar 2024

UAB study identifies new molecule for treating hypertension

Researchers at the UAB have carried out two revealing studies on TRPV2, a key ion channel in several cellular functions, which points to it as a possible new therapeutic target in the treatment of hypertension.

6 Mar 2024

Injectable hydrogel can mitigate right ventricular heart failure

An injectable hydrogel can mitigate damage to the right ventricle of the heart with chronic pressure overload, according to a new study published March 6 in Journal of the American College of Cardiology: Basic to Translational Science.

6 Mar 2024

Noninvasive gamma therapy may hold promise for treating chemo brain

Patients undergoing chemotherapy often experience cognitive effects such as memory impairment and difficulty concentrating - a condition commonly known as "chemo brain."

6 Mar 2024

New approach needed to better prepare and support women during menopause transition, experts say

A new approach to menopause that better prepares and supports women during midlife is needed – going beyond medical treatments, to empower women using high-quality information on symptoms and treatments, empathic clinical care and workplace adjustments as required, says a new four paper Series published in The Lancet.

6 Mar 2024

Scientists develop robust iPSC-derived rejuvenated T lymphocytes for cervical cancer treatment

Cervical cancer is among the most common malignancies affecting women worldwide. In 2020 alone, approximately 600,000 women were diagnosed with this disease, and over 314,000 died from it.

5 Mar 2024

Study shows semaglutide as a safe and effective therapy for MASLD in people with HIV

A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.

5 Mar 2024

Researchers take important step toward genetic therapy for hereditary conditions

Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss.

5 Mar 2024

Study finds lower cardiovascular risks in hyperthyroid patients treated with surgery or radioactive iodine

Hyperthyroidism, or overactive thyroid, happens when your thyroid gland makes more thyroid hormones than your body needs.

5 Mar 2024

Navigating the complexities of controlled release drug formulations

This interview aims to address the challenges and complexities involved in the development and manufacturing of controlled release drug formulations.

From DSI, a PLG Company 5 Mar 2024

New method simplifies production of limb progenitor cells from fibroblasts

In a collaborative study, researchers from Kyushu University and Harvard Medical School have identified proteins that can turn or "reprogram" fibroblasts - the most commonly found cells in skin and connective tissue - into cells with similar properties to limb progenitor cells.

4 Mar 2024

Unlocking the role of lncREST RNA in DNA replication and repair

Researchers at Cima Universidad de Navarra have discovered that a ribonucleic acid that does not contain information to make proteins (long non-coding RNA) plays a crucial role in signalling and repairing errors in DNA replication during cell division.

4 Mar 2024

New hope for binge eating and bulimia: GLP-1 drugs could be the key

GLP-1 receptor agonists show promise in reducing binge eating behaviors in disorders like bulimia nervosa, offering a new avenue for treatment with minimal side effects.

4 Mar 2024

Therapy News and Research

Understanding long COVID: A call for better diagnosis and treatment

Breakthrough in CRISPR delivery promises safer gene editing

Inherited genetic factors may predict elevated risk of new cancers among childhood cancer survivors

Research on fishing as PTSD treatment gets a $1.3 million funding boost

Combining virtual reality and electric brain stimulation may be a promising treatment strategy for PTSD

When it comes to ketamine, Meta’s posting policy is no party to decipher

Gut bacteria strains could be the key to predicting cancer treatment success

Research project receives 25 million U.S. dollars to develop drugs against childhood cancers

UAB study identifies new molecule for treating hypertension

Injectable hydrogel can mitigate right ventricular heart failure

Noninvasive gamma therapy may hold promise for treating chemo brain

New approach needed to better prepare and support women during menopause transition, experts say

Scientists develop robust iPSC-derived rejuvenated T lymphocytes for cervical cancer treatment

Study shows semaglutide as a safe and effective therapy for MASLD in people with HIV

Researchers take important step toward genetic therapy for hereditary conditions

Study finds lower cardiovascular risks in hyperthyroid patients treated with surgery or radioactive iodine

Navigating the complexities of controlled release drug formulations

New method simplifies production of limb progenitor cells from fibroblasts

Unlocking the role of lncREST RNA in DNA replication and repair

New hope for binge eating and bulimia: GLP-1 drugs could be the key

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News